These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 13463086)

  • 1. Further observations on the hemodynamic effect of plasma volume expansion by dextran.
    FLEMING JW; BLOOM WL
    J Clin Invest; 1957 Aug; 36(8):1233-8. PubMed ID: 13463086
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolic and hemodynamic changes induced by the prolonged administration of dextran.
    JAENIKE JR; WATERHOUSE C
    Circulation; 1955 Jan; 11(1):1-13. PubMed ID: 13231240
    [No Abstract]   [Full Text] [Related]  

  • 3. Dextran as a plasma substitute with plasma volume and excretion studies on control patients.
    HARRISON JH
    Ann Surg; 1954 Feb; 139(2):137-42. PubMed ID: 13125244
    [No Abstract]   [Full Text] [Related]  

  • 4. Hemodynamic effects of anemia with and without plasma volume expansion.
    FOWLER NO; FRANCH RH; BLOOM WL
    Circ Res; 1956 May; 4(3):319-24. PubMed ID: 13317026
    [No Abstract]   [Full Text] [Related]  

  • 5. The plasma volume expanding effect of low viscous dextran and Macrodex.
    GELIN LE; SOLVELL L; ZEDERFELDT B
    Acta Chir Scand; 1961 Nov; 122():309-23. PubMed ID: 13897609
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hemodynamic investigations of the new plasma substitute subsidon].
    KANIAK EG
    Arzneimittelforschung; 1952 Apr; 2(4):189-92. PubMed ID: 14944496
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiocirculatory and biochemical effects of dextran 1.8% and ringer's lactate after minor surgical procedures.
    Suter PM; Sadowski J; Gemperle M; Hemmer M
    Infusionsther Klin Ernahr; 1976 Dec; 3(6):327-9. PubMed ID: 1034621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The plasma volume expanding effect of low molecular weight dextran in the hypothermic dog.
    DRAKE CT; LEWIS FJ
    Surg Forum; 1961; 12():182-4. PubMed ID: 13887717
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of the peripheral and central hemodynamic effects of regular and low molecular weight dextran in patients with ischemic limbs.
    Folse R; Cope JG
    Surgery; 1965 Nov; 58(5):779-88. PubMed ID: 5845181
    [No Abstract]   [Full Text] [Related]  

  • 10. [Replacement therapy using macromolecules: general hemodynamic effects].
    Conseiller C; Viars P
    Anesth Analg (Paris); 1976; 3(4):633-46. PubMed ID: 1015651
    [No Abstract]   [Full Text] [Related]  

  • 11. The determinants of the efficacy of various expanders in plasma volume expansion and maintenance in normal subjects.
    METCALF W; ROUSSELOT LM; HARMON JM; GILBERTSON FE
    Surg Forum; 1953 Oct; 4():714-9. PubMed ID: 13187372
    [No Abstract]   [Full Text] [Related]  

  • 12. Hemodynamic properties of low-molecular weight dextran under experimental clinical conditions.
    Rudowski W; Kostrzewska E; Scharf R; Konopka L; Gregor A; Rechowicz K; Czartoryska B; Klawe Z; Ostrowski J
    Pol Med J; 1968; 7(4):851-7. PubMed ID: 5727932
    [No Abstract]   [Full Text] [Related]  

  • 13. Relative importance of dextran molecular size in plasma volume expansion.
    Wasserman K; Mayerson HS
    Am J Physiol; 1954 Jan; 176(1):104-12. PubMed ID: 13124504
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of various priming solutions upon red cell mass, plasma volume, and extracellular fluid volume of dogs following hemodilution technique of extracorporeal circulation.
    Hara M; Maris M; Crumpler J; Corn B; Perkins WH
    J Thorac Cardiovasc Surg; 1967 Mar; 53(3):353-9. PubMed ID: 6019148
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemodilution and changes in hemostasis induced by dextran. An experiment in dogs with and without plasma volume expansion.
    BLOOM WL; FOWLER NO; WARD JA; FRANCH RH
    J Surg Res; 1963 May; 3():152-8. PubMed ID: 13971788
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of plasma-volume expansion on portal hypertension.
    Boyer JL; Chatterjee C; Iber FL; Basu AK
    N Engl J Med; 1966 Oct; 275(14):750-5. PubMed ID: 5332146
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of hemodynamic dextran-based plasma substitutes in blood transfusion].
    Bohatyr'ova RV; Horban'EM ; Perekhrestenko PM; Maksymov IuM; Novak VL
    Klin Khir; 1997; (11-12):85-8. PubMed ID: 9615020
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemodynamic changes in graded hemorrhage with special reference to the peripheral circulation.
    PADHI RK; NANSON EM; LYNN RB
    Ann Surg; 1958 Nov; 148(5):827-34. PubMed ID: 13595544
    [No Abstract]   [Full Text] [Related]  

  • 19. [Newly developed plasma expanders, Haimasol (3 per cent dextran 40-L-R), 6 per cent dextran 70-L-R and Homeosol (acetic acid Ringer); their effects on the distribution of the body fluids].
    Fukuda Y; Fujita T; Sudo T; Sudo I; Tosawa T
    Masui; 1969 Oct; 18(10):973-84. PubMed ID: 5390137
    [No Abstract]   [Full Text] [Related]  

  • 20. [Attempted evaluation of the rheological properties of dextran 40 "Polfa"].
    Kostrzewska E; Gregor A
    Pol Tyg Lek; 1969 Jul; 24(27):1051-4. PubMed ID: 5805884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.